Adverum prepares pivotal study for wet AMD gene therapy, touts Phase 2 data

Max Gelman

Senior Editor

Adverum Biotechnologies’ eye disease gene therapy has traversed a rocky road of safety troubles, but the company — presenting new Phase 2 data in wet AMD …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Adverum prepares pivotal study for wet AMD gene therapy, touts Phase 2 data

Max Gelman

Senior Editor

Sign up to read this article for free.

Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find ...

For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Sanofi introduces new 340B payment model — report

Are programs with compounded GLP-1s safe for your population?

Ad­verum pre­pares piv­otal study for wet AMD gene ther­a­py, touts Phase 2 da­ta

Max Gelman

Senior Editor

Sign up to read this article for free.

Trump an­nounces picks for FDA, CDC; No­var­tis seeks bolt-on deals, rais­es guid­ance; RFK Jr., Elon Musk may find ...

For CDC, Trump picks Dave Wel­don, a for­mer con­gress­man who pushed for vac­cine in­jury claims

Trump names Johns Hop­kins re­searcher Mar­ty Makary to lead the FDA; al­so names CDC, Sur­geon Gen­er­al picks

FDA ap­proves Bridge­Bio's heart dis­ease drug, set­ting up com­pe­ti­tion with Pfiz­er, Al­ny­lam

Sanofi in­tro­duces new 340B pay­ment mod­el — re­port

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

Adverum prepares pivotal study for wet AMD gene therapy, touts Phase 2 data

Trump announces picks for FDA, CDC; Novartis seeks bolt-on deals, raises guidance; RFK Jr., Elon Musk may find ...

For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims

Trump names Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, Surgeon General picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

Sanofi introduces new 340B payment model — report

Are programs with compounded GLP-1s safe for your population?